kotak-logo
Open Demat Account
Wanbury Share Price

Wanbury Share Price

261.84
+2.14 (0.82%)
NSE
BSE
NSE: WANBURY | BSE: 524212 | | | as on 20 Apr, 2026 • 03:29 PM IST
Buy

Wanbury Annualised Return

1 Year

▼-3.18%

3 Years

▲86.15%

5 Years

▲22.05%

10 Years

▲17.58%

Wanbury Share Price Today


As of 21 Apr 2026, Wanbury share price is ₹261.8. The stock opened at ₹262 and had closed at ₹259.7 the previous day. During today’s trading session, Wanbury share price moved between ₹256.00 and ₹269.00, with an average price for the day of ₹262.50. Over the last 52 weeks, the stock has recorded a low of ₹161.50 and a high of ₹329.70. In terms of performance, Wanbury share price has increased by 13.9% over the past six months and has declined by 3.18% over the last year.

Wanbury Stock Performance

1W Return3.97
1Y Return-0.62
Today's Low256
Prev. Close259.70
Mkt Cap (Cr.)914.85
1M Return5.45
3Y Return588.15
52-Week High329.7
Open261.99
PE Ratio14.07
6M Return14.42
Today's High269
52-Week Low161.5
Face Value10

Wanbury Company background

Founded in: 1988
Wanbury Limited, formerly known Pearl Organics Limited was incorporated in August, 1988. The Company attained its present name in September 2004. The Company is engaged in the business of pharmaceutical and related activities, including research.The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.In 200708, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007. Pursuant to the aforesaid Order of the Honble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/ each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008. Similarly, the Pharmaceutical Products of India Limited (PPIL) was merged with the Company effective from April 1, 2006. In terms of the said Scheme of Merger, the Company had issued 5,62,618 Equity Shares of face value of Rs. 10/ each to the Equity Shareholders of PPIL on 27 June, 2007, which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively.The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in Zurich,Switzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008.The novel product Cdense Gems was launched in May, 2008. The Company completed the restructuring of the Formulation Division during the year 2013. It launched, MyotolF, targeted at female infertility in 2013, it launched Folinine. The Companys newly launched products MyotolF (to treat polycystic ovarian syndrome) and CalK2 (in prevention and management of Osteoporosis) were labelled as one of the best launches in 2014.

Wanbury Financial Highlights


For the full year FY2025–2026, revenue reached ₹603.01 crore and profit touched at ₹30.53 crore.
Read More
Wanbury SIP Return Calculator
₹5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹5,49,146 in 5 years with a gain of ₹2,49,146 (+83.05%)
Start SIP

Wanbury Fundamental

Market Cap (in crs)

914.85

Face Value

10

Turnover (in lacs)

102.33

Key Metrics

Qtr Change %
62.13% Gain from 52W Low
23.8
Dividend yield 1yr %
0

Wanbury Key Financials

View more
Loading chart...
Wanbury Quarterly Revenue
Wanbury Yearly Revenue
Wanbury Quarterly Net Profit/Loss
Wanbury Yearly Net Profit/Loss

Wanbury Result Highlights

  • Wanbury reported a 16.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 23.8%.

  • Its expenses for the quarter were up by 13.6% QoQ and 14.4% YoY.

  • The net profit decreased 59.9% QoQ and increased 1197.1% YoY.

  • The earnings per share (EPS) of Wanbury stood at 4 during Q1 FY 2025-26.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Wanbury Technical Analysis

Moving Averages Analysis
261.84
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5 EMA
258.10
10 EMA
251.50
12 EMA
249.90
20 EMA
246.80
26 EMA
245.90
50 EMA
243.70
100 EMA
242.80
200 EMA
243.80
Delivery & Volume
Loading chart...

Delivery Volume %

Day

100.00%

Week

100.00%

Month

100.00%

Delivery & Volume

Resistance & Support

262.28
Pivot
Resistance
First Resistance
268.56
Second Resistance
275.28
Third Resistance
281.56
Support
First Support
255.56
Second support
249.28
Third Support
242.56
Relative Strength Index
60.24
Money Flow Index
61.29
MACD
3.99
MACD Signal
0.10
Average True Range
13.67
Average Directional Index
16.55
Rate of Change (21)
5.97
Rate of Change (125)
5.82

Wanbury Peer comparison

Compare

Wanbury Shareholding Pattern

Promoter
43%
Foreign Institutions
0.6%
Public
56.4%

Wanbury Latest News

08 APR 2026

Wanbury - 524212 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

06 APR 2026

Wanbury - 524212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

26 MAR 2026

Wanbury - 524212 - Closure of Trading Window

View More

Wanbury Share Price FAQs

Wanbury share price is ₹261.84 in NSE and ₹260.35 in BSE as on 20/4/2026.

Wanbury share price in the past 1-year return was -0.61. The Wanbury share hit a 1-year low of Rs. 161.5 and a 1-year high of Rs. 329.7.

The market cap of Wanbury is Rs. 914.85 Cr. as of 20/4/2026.

The PE ratios of Wanbury is 14.07 as of 20/4/2026.

The PB ratios of Wanbury is 8.47 as of 20/4/2026

You can easily buy Wanbury shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Wanbury share price is ₹329.7 and ₹161.5 as of 20/4/2026.

Please be aware that Wanbury stock prices are subject to continuous fluctuations due to various factors.